Federal contractor · public award history
ORGANON LLC
DBA ORGANON & CO OF DELAWARE, INC
Parent: ORGANON LLC R6PBPDWXY8Y4
- Awards we know about
- 4
- Typical size
- —
- Middle of their public awards
- Dollars on those awards
- $0
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- May 11, 2027
- Activation date
- May 13, 2026
- Primary NAICS (SAM)
- 325412
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (4)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
NEW AWARD FOR RENFLEXIS (INFLIXIMAB-ABDA) 100MG VIAL WITH ORGANON LLC. ORDERING PERIOD IS SEPTEMBER 1, 2023 TO AUGUST 31, 2024 WITH FOUR ONE-YEAR OPTIONS.
- Department of Veterans Affairs—
ADALIMUMAB GROUP I, LINE ITEMS 1 AND 2 AND GROUP II LINE ITEMS 1 AND 2. AWARDED FOR A BASE YEAR OF 3/9/2024 TO 3/8/2025 PLUS FOUR ONE YEAR OPTION PERIODS.
- Department of Veterans Affairs—
NEW CONTRACT AWARD ONTRUZANT(TRASTUZUMAB) 150MG WITH MERCK FOR A BASE PLUS FOUR ONE YEAR OPTIONS
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.